Health Condition 1: N898- Other specified noninflammatory disorders of vagina
Conditions
Interventions
Intervention1: Safoof Makhana: 6gm (Powder) orally with milk before breakfast for 28days
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients in the age group of 14-45 years. 2. Patients having excessive white discharge with or without any of the following associated symptoms a. Waja‘ al-Zahr (Backache) b. Naqahat (General Weakness) c. Burning Micturition d. Pruritus vulvae
Exclusion criteria
Exclusion criteria: 1. Patients having acute/ acute on chronic/Chronic PIDs (as per the CDC Diagnostic Criteria attached as an annexure-V) 2. Patients with diseases requiring long-term treatment. 3. Patients on Oral Contraceptives/IUDs. 4. Patients taking hormonal therapy. 5. Any abnormal condition on p/s Examination. 6. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drugs will be assessed on the basis of improvement in the following symptoms for which a 10-point Visual Analog Scale (VAS) will be applied. • Amount of Vaginal Discharge (rated according to the number of pads used in a day) • Waja‘ al-Zahr (Backache) • Naqahat (General Weakness) • Burning Micturition • Pruritus vulvaeTimepoint: At baseline, 7th day, 14th day and at the end of study i.e. 28days | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and at the end of study i.e. 28days | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed